Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.50 is 78% above its 5-year average of -2.25, near the high end of its 5-year range (-3.83–-0.50).
80.04% above its 12-month average of -2.50.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.50
EARNINGS PER SHARE (EPS) AVG TTM
-2.50
EARNINGS PER SHARE (EPS) AVG 3Y
-2.81
EARNINGS PER SHARE (EPS) AVG 5Y
-2.25
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+80.04%
CURRENT VS 3Y AVG
+82.22%
CURRENT VS 5Y AVG
+77.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Biomea Fusion, Inc.
Market Cap
$90.37M
Earnings Per Share (EPS)
-0.50
TTM Avg
-2.50
3Y Avg
-2.81
5Y Avg
-2.25
Market Cap
$90.38M
Earnings Per Share (EPS)
0.08
TTM Avg
-0.19
3Y Avg
-0.36
5Y Avg
-0.27
Market Cap
$91.24M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.62
3Y Avg
-2.84
5Y Avg
-4.12
Market Cap
$89.15M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.31
3Y Avg
-0.33
5Y Avg
-0.76
Market Cap
$92.88M
Earnings Per Share (EPS)
-1.23
TTM Avg
-1.49
3Y Avg
-1.33
5Y Avg
-1.26
Market Cap
$86.90M
Earnings Per Share (EPS)
0.07
TTM Avg
-0.09
3Y Avg
-1.24
5Y Avg
-1.25
Market Cap
$85.17M
Earnings Per Share (EPS)
-0.60
TTM Avg
-0.82
3Y Avg
-0.86
5Y Avg
-0.88
Market Cap
$86.59M
Earnings Per Share (EPS)
-1.18
TTM Avg
-4.40
3Y Avg
-32.48
5Y Avg
-54.06
Market Cap
$86.67M
Earnings Per Share (EPS)
-0.57
TTM Avg
-1.79
3Y Avg
-1.21
5Y Avg
-1.06
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $90.37M | -0.50 | -2.50 | -2.81 | -2.25 |
| ImmuCell Corporation (ICCC)vs › | $90.38M | 0.08 | -0.19 | -0.36 | -0.27 |
| electroCore, Inc. (ECOR)vs › | $91.24M | -1.70 | -1.62 | -2.84 | -4.12 |
| Equillium, Inc. (EQ)vs › | $89.15M | -0.26 | -0.31 | -0.33 | -0.76 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $92.88M | -1.23 | -1.49 | -1.33 | -1.26 |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 0.07 | -0.09 | -1.24 | -1.25 |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.17M | -0.60 | -0.82 | -0.86 | -0.88 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.59M | -1.18 | -4.40 | -32.48 | -54.06 |
| Nutriband Inc. (NTRB)vs › | $86.67M | -0.57 | -1.79 | -1.21 | -1.06 |
| Korro Bio, Inc. (KRRO)vs › | $94.76M | -10.01 | -10.93 | -75.63 | -58.09 |
Trailing EPS (TTM)
$-0.50
Forward EPS (Est.)
$-0.78
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.18 |
| 2024-12-31 | -3.83 |
| 2023-12-31 | -3.44 |
| 2022-12-31 | -2.80 |
| 2021-12-31 | -1.74 |
| 2020-12-31 | -0.50 |
| 2019-12-31 | -0.11 |
